|
Market Closed -
Nasdaq
00:00:00 14/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.160 USD | +21.07% |
|
+7.41% | -28.83% |
| 11-13 | Codexis, Inc., Q3 2026 Earnings Call, Nov 12, 2026 | |
| 11-13 | Codexis Q3 Loss Narrows, Revenue Rises | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CODEXIS, INC. | Other Biotechnology & Medical Research | +21.07% | +7.41% | -28.83% | -29.48% | -96.80% | 127M |
- Stock Market
- Stocks
- CDXS Stock
- Charts Codexis, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















